MAM
LPCN icon

Meeder Asset Management’s Lipocine LPCN Stock Holding History

Meeder Asset Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$7K – 2214
2019
Q2 		$7K Hold
200
– – ﹤0.01% 1567
2019
Q1 		$8K Sell
200
-177
-47% -$5.43K ﹤0.01% 1296
2018
Q4 		$8K Buy
377
+25
+7% +$580 ﹤0.01% 1306
2018
Q3 		$8K Buy
352
+212
+151% +$5.21K ﹤0.01% 1210
2018
Q2 		$3.1K Sell
140
-4
-3% -$95 ﹤0.01% 1349
2018
Q1 		$4K Sell
144
-4
-3% -$111 ﹤0.01% 1280
2017
Q4 		$9K Buy
148
+51
+53% +$3.17K ﹤0.01% 1152
2017
Q3 		$7K Buy
97
+54
+126% +$3.9K ﹤0.01% 1165
2017
Q2 		$3K Buy
43
+4
+10% +$261 ﹤0.01% 1328
2017
Q1 		$3K Sell
39
-168
-81% -$10.9K ﹤0.01% 1266
2016
Q4 		$13K Sell
207
-29
-12% -$1.84K ﹤0.01% 712
2016
Q3 		$18K Buy
+236
New +$14.6K ﹤0.01% 692

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Meeder Asset Management's LPCN Position: Q3 2019 in Review

Meeder Asset Management sold out of Lipocine (LPCN) in Q3 2019, closing a stake of 200 shares — an estimated $7K sold.

Meeder Asset Management first reported a position in LPCN in Q3 2016 and held it in 12 quarters. The position peaked at $18K in Q3 2016. 30 funds tracked by Wall St. Rank hold LPCN as of Q3 2019.

  • Meeder Asset Management reported no remaining Lipocine position as of Q3 2019 after selling out during the quarter.
  • Meeder Asset Management sold 200 Lipocine shares in Q3 2019, an estimated $7K.
  • Meeder Asset Management first reported a position in Lipocine in Q3 2016 and held it in 12 quarters.
  • Meeder Asset Management's Lipocine position peaked at $18K in Q3 2016.
  • 30 funds tracked by Wall St. Rank held Lipocine as of Q3 2019.

Based on Meeder Asset Management's 13F filing for Q3 2019, filed 17 Oct 2019.